Myeloid-related protein 8/14 levels in children with obstructive sleep apnoea

European Respiratory Journal

Volumn 35, Issue 4, 2010, Pages 843-850

  Kim, J ^a   Bhattacharjee, R ^b   Snow, A B ^b   Capdevila, O S ^b   Kheirandish Gozal, L ^a   Gozal, D ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CALGRANULIN A; CALGRANULIN B; INTERLEUKIN 6;

ARTICLE; BODY MASS; BRACHIAL ARTERY; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CELL FUNCTION; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SLEEP APNEA SYNDROME;

C-REACTIVE PROTEIN; CALGRANULIN A; CALGRANULIN B; CHILD; CHILD, PRESCHOOL; ENDOTHELIUM; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MORBIDITY; OBESITY; ODDS RATIO; POLYSOMNOGRAPHY; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SLEEP APNEA, OBSTRUCTIVE;

EID: 77951199837     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00075409     Document Type: Article

References (63)

1. Kushida CA, Chediak A, Berry RB, et al. Clinical guidelines for the manual titration of positive airway pressure in patients with obstructive sleep apnea. J Clin Sleep Med 2008; 4: 157-171. (Pubitemid 352038657)
2. Shamsuzzaman AS, Gersh BJ, Somers VK. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 2003; 290: 1906-1914. (Pubitemid 37430608)
3. Bhattacharjee R, Kheirandish-Gozal L, Pillar G, et al. Cardiovascular complications of obstructive sleep apnea syndrome: evidence from children. Prog Cardiovasc Dis 2009; 51: 416-433.
4. Gozal D, Capdevila OS, Kheirandish-Gozal L. Metabolic alterations and systemic inflammation in obstructive sleep apnea among nonobese and obese prepubertal children. Am J Respir Crit Care Med 2008; 177: 1142-1149. (Pubitemid 351717574)
5. Capdevila OS, Kheirandish-Gozal L, Dayyat E, et al. Pediatric obstructive sleep apnea: complications, management, and long-term outcomes. Proc Am Thorac Soc 2008; 5: 274-282. (Pubitemid 351237887)
6. Tauman R, Gozal D. Obesity and obstructive sleep apnea in children. Paediatr Respir Rev 2006; 7: 247-259. (Pubitemid 44767192)
7. Atkeson A, Yeh SY, Malhotra A, et al. Endothelial function in obstructive sleep apnea. Prog Cardiovasc Dis 2009; 51: 351-362.
8. Jelic S, Le Jemtel TH. Inflammation, oxidative stress, and the vascular endothelium in obstructive sleep apnea. Trends Cardiovasc Med 2008; 18: 253-260.
9. Hatipoglu U, Rubinstein I. Inflammation and obstructive sleep apnea syndrome pathogenesis: a working hypothesis. Respiration 2003; 70: 665-671. (Pubitemid 38142324)
10. Ahmad A, Bayley DL, He S, et al. Myeloid related protein-8/14 stimulates interleukin-8 production in airway epithelial cells. Am J Respir Cell Mol Biol 2003; 29: 523-530. (Pubitemid 37222691)
11. Rammes A, Roth J, Goebeler M, et al. Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulindependent pathway. J Biol Chem 1997; 272: 9496-9502. (Pubitemid 27154966)
12. Stroncek DF, Shankar RA, Skubitz KM. The subcellular distribution of myeloid-related protein 8 (MRP8) and MRP14 in human neutrophils. J Transl Med 2005; 3: 36.
13. Pouliot P, Plante I, Raquil MA, et al. Myeloid-related proteins rapidly modulate macrophage nitric oxide production during innate immune response. J Immunol 2008; 181: 3595-3601.
14. Guignard F, Mauel J, Markert M. Phosphorylation of myeloid-related proteins MRP-14 and MRP-8 during human neutrophil activation. Eur J Biochem 1996; 241: 265-271. (Pubitemid 26342998)
15. Morrow DA, Wang Y, Croce K, et al. Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial. Am Heart J 2008; 155: 49-55. (Pubitemid 350234770)
16. Healy AM, Pickard MD, Pradhan AD, et al. Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events. Circulation 2006; 113: 2278-2284.
17. Eue I, Langer C, Eckardstein A, et al. Myeloid related protein (MRP) 14 expressing monocytes infiltrate atherosclerotic lesions of ApoE null mice. Atherosclerosis 2000; 151: 593-597.
18. Viemann D, Strey A, Janning A, et al. Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells. Blood 2005; 105: 2955-2962. (Pubitemid 40446292)
19. Gozal D, Serpero LD, Sans Capdevila O, et al. Systemic inflammation in non-obese children with obstructive sleep apnea. Sleep Med 2008; 9: 254-259. (Pubitemid 351387097)
20. Gozal D, Crabtree VM, Sans Capdevila O, et al. C-reactive protein, obstructive sleep apnea, and cognitive dysfunction in school-aged children. Am J Respir Crit Care Med 2007; 176: 188-193. (Pubitemid 47057856)
21. Tauman R, Ivanenko A, O'Brien LM, et al. Plasma C-reactive protein levels among children with sleep-disordered breathing. Pediatrics 2004; 113: e564-e569.
22. Gozal D, Kheirandish-Gozal L, Serpero LD, et al. Obstructive sleep apnea and endothelial function in school-aged nonobese children: effect of adenotonsillectomy. Circulation 2007; 116: 2307-2314. (Pubitemid 350100337)
23. American Diabetes Association. Diabetes basics. Symptoms. Available from: www.diabetes.org/pre-diabetes/pre-diabetes-symptoms.jsp Date last accessed: February 9, 2010.
24. Centers for Disease Control and Prevention. CDC Growth Charts. Available from: www.cdc.gov/growthcharts Date last updated: August 4, 2009; date last accessed: February 9, 2010.
25. Rechstschaffen A., Kales A, eds. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Los Angeles, Brain Information Services/Brain Research Institute, 1968.
26. Standards and indications for cardiopulmonary sleep studies in children. American Thoracic Society. Am J Respir Critical Care Med 1996; 153: 866-878.
27. Montgomery-Downs HE, O'Brien LM, Gulliver TE, et al. Polysomnographic characteristics in normal preschool and early school-aged children. Pediatrics 2006; 117: 741-753.
28. The AASM Manual for the Scoring of Sleep and Associated Events. Rules, Terminology and Technical Specifications. Westchester, American Academy of Sleep Medicine, 2007.
29. EEG arousals: scoring rules and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep 1992; 15: 173-184.
30. Gozal D, Kheirandish-Gozal L. Cardiovascular morbidity in obstructive sleep apnea: oxidative stress, inflammation, and much more. Am J Respir Crit Care Med 2008; 177: 369-375. (Pubitemid 351317579)
31. Gozal D, Kheirandish L. Oxidant stress and inflammation in the snoring child: confluent pathways to upper airway pathogenesis and end-organ morbidity. Sleep Med Rev 2006; 10: 83-96.
32. Somers VK, White DP, Amin R, et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol 2008; 52: 686-717.
33. Saarelainen S, Seppala E, Laasonen K, et al. Circulating endothelin-1 in obstructive sleep apnea. Endothelium 1997; 5: 115-118. (Pubitemid 27273680)
34. Allahdadi KJ, Walker BR, Kanagy NL. Augmented endothelin vasoconstriction in intermittent hypoxia-induced hypertension. Hypertension 2005; 45: 705-709.
35. Gjorup PH, Sadauskiene L, Wessels J, et al. Abnormally increased endothelin-1 in plasma during the night in obstructive sleep apnea: relation to blood pressure and severity of disease. Am J Hypertens 2007; 20: 44-52. (Pubitemid 46014056)
36. Ip MS, Lam B, Chan LY, et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 2000; 162: 2166-2171. (Pubitemid 32051681)
37. Schulz R, Schmidt D, Blum A, et al. Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy. Thorax 2000; 55: 1046-1051.
38. Ohike Y, Kozaki K, Iijima K, et al. Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure - possible involvement of nitric oxide and asymmetric NG, NG-dimethylarginine. Circ J 2005; 69: 221-226. (Pubitemid 40313045)
39. Lavie L. Oxidative stress - a unifying paradigm in obstructive sleep apnea and comorbidities. Prog Cardiovasc Dis 2009; 51: 303-312.
40. Yamauchi M, Kimura H. Oxidative stress in obstructive sleep apnea: putative pathways to the cardiovascular complications. Antioxid Redox Signal 2008; 10: 755-768. (Pubitemid 351225902)
41. Tauman R, O'Brien LM, Gozal D. Hypoxemia and obesity modulate plasma C-reactive protein and interleukin-6 levels in sleep-disordered breathing. Sleep Breath 2007; 11: 77-84. (Pubitemid 46745859)
42. Kaditis AG, Alexopoulos EI, Kalampouka E, et al. Morning levels of fibrinogen in children with sleep-disordered breathing. Eur Respir J 2004; 24: 790-797. (Pubitemid 39504433)
43. O'Brien LM, Gozal D. Autonomic dysfunction in children with sleep-disordered breathing. Sleep 2005; 28: 747-752. (Pubitemid 40798717)
44. Baharav A, Kotagal S, Rubin BK, et al. Autonomic cardiovascular control in children with obstructive sleep apnea. Clin Auton Res 1999; 9: 345-351.
45. McConnell K, Somers VK, Kimball T, et al. Baroreflex gain in children with obstructive sleep apnea. Am J Respir Crit Care Med 2009; 180: 42-48.
46. Bixler EO, Vgontzas AN, Lin HM, et al. Blood pressure associated with sleep-disordered breathing in a population sample of children. Hypertension 2008; 52: 841-846.
47. Li AM, Au CT, Sung RY, et al. Ambulatory blood pressure in children with obstructive sleep apnoea: a community based study. Thorax 2008; 63: 803-809.
48. Amin R, Somers VK, McConnell K, et al. Activity-adjusted 24-hour ambulatory blood pressure and cardiac remodeling in children with sleep disordered breathing. Hypertension 2008; 51: 84-91. (Pubitemid 350307108)
49. Amin RS, Kimball TR, Bean JA, et al. Left ventricular hypertrophy and abnormal ventricular geometry in children and adolescents with obstructive sleep apnea. Am J Respir Crit Care Med 2002; 165: 1395-1399.
50. O'Brien LM, Serpero LD, Tauman R, et al. Plasma adhesion molecules in children with sleep-disordered breathing. Chest 2006; 129: 947-953. (Pubitemid 43740090)
51. Kheirandish-Gozal L, Capdevila OS, Tauman R, et al. Plasma Creactive protein in nonobese children with obstructive sleep apnea before and after adenotonsillectomy. J Clin Sleep Med 2006; 2: 301-304. (Pubitemid 44299553)
52. Kaditis AG, Alexopoulos EI, Kalampouka E, et al. Morning levels of C-reactive protein in children with obstructive sleep-disordered breathing. Am J Respir Crit Care Med 2005; 171: 282-286.
53. Taheri S, Austin D, Lin L, et al. Correlates of serum C-reactive protein (CRP) - no association with sleep duration or sleep disordered breathing. Sleep 2007; 30: 991-996.
54. Ford ES, Galuska DA, Gillespie C, et al. C-reactive protein and body mass index in children: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. J Pediatr 2001; 138: 486-492.
55. Bhardwaj RS, Zotz C, Zwadlo-Klarwasser G, et al. The calcium-binding proteins MRP8 and MRP14 form a membrane-associated heterodimer in a subset of monocytes/macrophages present in acute but absent in chronic inflammatory lesions. Eur J Immunol 1992; 22: 1891-1897.
56. Eue I, Pietz B, Storck J, et al. Transendothelial migration of 27E10+ human monocytes. Int Immunol 2000; 12: 1593-1604.
57. Schulze zur Wiesch A, Foell D, Frosch M, et al. Myeloid related proteins MRP8/MRP14 may predict disease flares in juvenile idiopathic arthritis. Clin Exp Rheumatol 2004; 22: 368-373.
58. Liao H, Wu J, Kuhn E, et al. Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. Arthritis Rheum 2004; 50: 3792-3803.
59. Altwegg LA, Neidhart M, Hersberger M, et al. Myeloid-related protein 8/14 complex is released by monocytes and granulocytes at the site of coronary occlusion: a novel, early, and sensitive marker of acute coronary syndromes. Eur Heart J 2007; 28: 941-948. (Pubitemid 47343918)
60. Bouma G, Lam-Tse WK, Wierenga-Wolf AF, et al. Increased serum levels of MRP-8/14 in type 1 diabetes induce an increased expression of CD11b and an enhanced adhesion of circulating monocytes to fibronectin. Diabetes 2004; 53: 1979-1986.
61. Burkhardt K, Schwarz S, Pan C, et al. Myeloid-related protein 8/14 complex describes microcirculatory alterations in patients with type 2 diabetes and nephropathy. Cardiovasc Diabetol 2009; 8: 10.
62. Agren K, Andersson U, Nordlander B, et al. Upregulated local cytokine production in recurrent tonsillitis compared with tonsillar hypertrophy. Acta Otolaryngol 1995; 115: 689-696.
63. Nacken W, Roth J, Sorg C, et al. S100A9/S100A8: Myeloid representatives of the S100 protein family as prominent players in innate immunity. Microsc Res Tech 2003; 60: 569-580.